WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Fermer ce répertoireEczematous diseases
Afficher le documentContact dermatitis
Afficher le documentAtopic dermatitis
Afficher le documentSeborrhoeic dermatitis
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Seborrhoeic dermatitis

Dandruff, an erythematous, greasy, scaling eruption primarily involving the scalp, is the mildest form of seborrhoeic dermatitis. Erythema and greasy scales are found commonly in the central portion of the face (eyebrows, glabella and nasolabial folds) as well as on the chest. A more florid form, in which the lesions are extensive and the inflammatory reaction intense, is frequently seen as an early cutaneous indicator of HIV infection. Seborrhoeic dermatitis in infants appears as a non-pruritic, erythematous, scaling dermatosis involving mainly the scalp and face.

Pityrosporum yeasts are presumed to play at least a facultative, and possibly a causative role in the development of seborrhoeic dermatitis. Androgens may also be involved since men are affected more frequently than women.

Management

Use of a keratolytic shampoo reduces both the inflammation and scaling. There are many detergent-based suspensions or shampoos available containing active agents such as salicylic acid, coal tar, pyrithione zinc and selenium sulfide.

Since good foaming action is required, the shampoo should be massaged into the scalp and left for at least 2-3 minutes before rinsing.

Preparations containing combinations of sulfur and salicylic acid can also be applied to the scalp and other affected areas. Topical applications of corticosteroids, methylrosanilinium chloride (gentian violet) and/or azoles such as ketoconazole are also reported to be effective.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012